There are more than 200 different types of cancer and experts say there are some early warning signs people are "most likely ...
A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...
One in 16 Americans will be diagnosed with lung cancer in their lifetime. As the leading cause of cancer deaths in the U.S., ...
Leads Biolabs receives US FDA orphan drug designation for anti-PD-L1/4-1BB bispecific antibody, LBL-024 for treatment of neuroendocrine cancer: Nanjing, China Saturday, November 2 ...
It’s being examined in a phase 1/2a study designed to enroll up to 15 patients for each of six different cohorts, spanning ...
A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that combining pembrolizumab, ...
The global neuroendocrine carcinoma treatment market is poised for substantial growth, with revenue expected to reach USD ...